Pre-immunotherapy radiotherapy enhanced the efficacy of multi-line sintilimab in unresectable advanced esophageal squamous cell carcinoma

BACKGROUND: The use of immunotherapy for the treatment of esophageal squamous cell carcinoma (ESCC) is gradually increasing. In this retrospective study, we evaluated the efficacy and explored potential factors of prognosis in multi-line sintilimab for unresectable advanced ESCC. METHODS: All pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shuhui, Xu, Xianxing, Zhu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986250/
https://www.ncbi.nlm.nih.gov/pubmed/36891294
http://dx.doi.org/10.3389/fimmu.2023.960339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986250/
https://www.ncbi.nlm.nih.gov/pubmed/36891294
http://dx.doi.org/10.3389/fimmu.2023.960339

Ejemplares similares